These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 33039312)

  • 21. Clinical pattern of systemic sclerosis in Central Ukraine. Association between clinical manifestations of systemic sclerosis and hypertension.
    Semenov V; Kuryata O; Lysunets T
    Reumatologia; 2018; 56(1):24-30. PubMed ID: 29686439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of the 2013 American College of Rheumatology/European League Against Rheumatism classification criteria for systemic sclerosis in patients from a capillaroscopy clinic.
    Melchor S; Joven BE; Andreu JL; Loza E; Garcia de Yebenes MJ; Carmona L; Carreira PE
    Semin Arthritis Rheum; 2016 Dec; 46(3):350-355. PubMed ID: 27373498
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Associations of right ventricular myocardial function with skin and pulmonary involvement in asymptomatic patients with systemic sclerosis.
    D'Andrea A; Bellissimo S; Scotto di Uccio F; Vigorito F; Moscato F; Tozzi N; Di Donato M; Citro R; Stisi S; Scherillo M
    Ital Heart J; 2004 Nov; 5(11):831-9. PubMed ID: 15633438
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The concept of early systemic sclerosis following 2013 ACR\EULAR criteria for the classification of systemic sclerosis.
    Valentini G; Marcoccia A; Cuomo G; Iudici M; Vettori S
    Curr Rheumatol Rev; 2014; 10(1):38-44. PubMed ID: 24720644
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic dyspnea with Raynaud's phenomenon and elevated ANA: A diagnosis of systemic sclerosis sine scleroderma.
    Chong WH; Saha BK; Beegle S
    Am J Med Sci; 2023 Feb; 365(2):198-204. PubMed ID: 35276077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nintedanib in Patients With Systemic Sclerosis-Associated Interstitial Lung Disease: Subgroup Analyses by Autoantibody Status and Modified Rodnan Skin Thickness Score.
    Kuwana M; Allanore Y; Denton CP; Distler JHW; Steen V; Khanna D; Matucci-Cerinic M; Mayes MD; Volkmann ER; Miede C; Gahlemann M; Quaresma M; Alves M; Distler O
    Arthritis Rheumatol; 2022 Mar; 74(3):518-526. PubMed ID: 34514739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Computer-Aided Tomographic Analysis of Interstitial Lung Disease (ILD) in Patients with Systemic Sclerosis (SSc). Correlation with Pulmonary Physiologic Tests and Patient-Centred Measures of Perceived Dyspnea and Functional Disability.
    Salaffi F; Carotti M; Di Donato E; Di Carlo M; Ceccarelli L; Giuseppetti G
    PLoS One; 2016; 11(3):e0149240. PubMed ID: 26930658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telangiectasia as a potential clinical marker of microvascular lesions in systemic sclerosis patients from EUSTAR data in China.
    Zhang SZ; Xu D; Li MT; Hou Y; Wang Q; Tian Z; Liu YT; Guo XX; Lai JZ; Zhao JL; Hu CJ; Song N; Sun QN; Zhang FC; Zhao Y; Zeng XF
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S106-10. PubMed ID: 26005882
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The 2013 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Systemic Sclerosis Could Classify Systemic Sclerosis Patients at Earlier Stage: Data from a Chinese EUSTAR Center.
    Xu D; Hou Y; Zheng Y; Zheng Y; Li M; Zeng X
    PLoS One; 2016; 11(11):e0166629. PubMed ID: 27851803
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between Interstitial Lung Disease Morphology Scores Based on High-resolution Computed Tomography Chest and Skin Fibrosis Degree Based on Modified Rodnan's Skin Score on Systemic Sclerosis.
    Hikmat IH; Ramdhini SS; Soekersi H; Dewi S
    Acta Med Indones; 2021 Jul; 53(3):254-260. PubMed ID: 34611063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Significance of anti-tubulin-α-1C autoantibody in systemic sclerosis].
    Zhao J; Sun F; Li Y; Zhao XZ; Xu D; Li YN; Li YH; Sun XL
    Beijing Da Xue Xue Bao Yi Xue Ban; 2020 Dec; 52(6):1009-1013. PubMed ID: 33331306
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical features of systemic sclerosis and association with antitopoisomerase-1 antibody and centromere pattern of antinuclear antibody].
    Bertazzi GR; de Toledo RA; de Godoy MF; Geraldino GC; Polizelli DV; Fernandes GC; Pedroso CL; dos Santos FG; de Assis TM
    Acta Reumatol Port; 2012; 37(1):9-17. PubMed ID: 22781510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Characteristics of patients with systemic sclerosis who develop interstitial lung disease].
    Fajardo-Hermosillo LD; Ocampo-Torres MC; Rodríguez-Silverio J
    Rev Med Inst Mex Seguro Soc; 2023 Oct; 61(Suppl 3):S363-S371. PubMed ID: 37934671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CREST Syndrome in Systemic Sclerosis Patients - Is Dystrophic Calcinosis a Key Element to a Positive Diagnosis?
    Bobeica C; Niculet E; Craescu M; Parapiru EL; Musat CL; Dinu C; Chiscop I; Nechita L; Debita M; Stefanescu V; Stefanopol IA; Nechifor A; Pelin AM; Balan G; Chirobocea S; Vasile CI; Tatu AL
    J Inflamm Res; 2022; 15():3387-3394. PubMed ID: 35706527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating Collagen Metabolites and the Enhanced Liver Fibrosis (ELF) Score as Fibrosis Markers in Systemic Sclerosis.
    Chen C; Wang L; Wu J; Lu M; Yang S; Ye W; Guan M; Liang M; Zou H
    Front Pharmacol; 2022; 13():805708. PubMed ID: 35177989
    [No Abstract]   [Full Text] [Related]  

  • 36. Clinical and autoantibody profiles of systemic sclerosis patients: A cross-sectional study from North India.
    Ghosh S; Tanna D; Telang K; Dhuria S; Gupta R
    Indian J Dermatol Venereol Leprol; 2023 Jul; ():1-7. PubMed ID: 37436007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progression of patients with Raynaud's phenomenon to systemic sclerosis: a five-year analysis of the European Scleroderma Trial and Research group multicentre, longitudinal registry study for Very Early Diagnosis of Systemic Sclerosis (VEDOSS).
    Bellando-Randone S; Del Galdo F; Lepri G; Minier T; Huscher D; Furst DE; Allanore Y; Distler O; Czirják L; Bruni C; Guiducci S; Avouac J; Cutolo M; Smith V; Matucci-Cerinic M;
    Lancet Rheumatol; 2021 Dec; 3(12):e834-e843. PubMed ID: 38287630
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and laboratory features of African-Brazilian patients with systemic sclerosis.
    Mendes C; Viana VST; Pasoto SG; Leon EP; Bonfa E; Sampaio-Barros PD
    Clin Rheumatol; 2020 Jan; 39(1):9-17. PubMed ID: 31065858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences in early systemic sclerosis patients: a report from the EULAR scleroderma trials and research group (EUSTAR) database.
    Carreira PE; Carmona L; Joven BE; Loza E; Andreu JL; Riemekasten G; Vettori S; Balbir-Gurman A; Airò P; Walker UA; Damjanov N; Matucci-Cerinic M; Ananieva LP; Rednic S; Czirják L; Distler O; Farge D; Hesselstrand R; Corrado A; Caramaschi P; Tikly M; Allanore Y;
    Clin Exp Rheumatol; 2018; 36 Suppl 113(4):68-75. PubMed ID: 30277860
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Validation of the ACR/EULAR classification criteria for systemic sclerosis in patients with early scleroderma.
    Araújo FC; Camargo CZ; Kayser C
    Rheumatol Int; 2017 Nov; 37(11):1825-1833. PubMed ID: 28819792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.